filmov
tv
Two years into the COVID-19 pandemic... What can serology testing tell us about immune status?
Показать описание
Presented By:
Anne-Geneviève Marcelin
Professor of virology at Sorbonne Université, Clinical virologist at Pitié-Salpêtrière Hospital
Jean-François Mouscadet
Associate Vice President of Research & Development, Bio-Rad Laboratories, Clinical Diagnostics
Heidi Scholz
Research & Development Manager, Bio-Rad Laboratories - Clinical Immunology
Webinar:
Two years into the COVID-19 pandemic... What can serology testing tell us about immune status?
Webinar Abstract:
As of May 2022, there have been more than 500 million confirmed cases of COVID-19. Additionally, more than 5 billion people have received at least one dose of a COVID-19 vaccine. Immune responses to natural COVID-19 infections, including to the numerous variants and subvariants, and to the variety of available vaccines are unique.
Two years into the global COVID-19 pandemic, the role of serology testing to evaluate immune responses has not yet been defined. This webinar will explore the role of serology testing to assess immune status.
Bio-Rad SARS-CoV-2 products provide you and your laboratory with efficient new ways to quantitatively characterize immune responses.
LabRoots on Social:
SnapChat: labroots_inc
Anne-Geneviève Marcelin
Professor of virology at Sorbonne Université, Clinical virologist at Pitié-Salpêtrière Hospital
Jean-François Mouscadet
Associate Vice President of Research & Development, Bio-Rad Laboratories, Clinical Diagnostics
Heidi Scholz
Research & Development Manager, Bio-Rad Laboratories - Clinical Immunology
Webinar:
Two years into the COVID-19 pandemic... What can serology testing tell us about immune status?
Webinar Abstract:
As of May 2022, there have been more than 500 million confirmed cases of COVID-19. Additionally, more than 5 billion people have received at least one dose of a COVID-19 vaccine. Immune responses to natural COVID-19 infections, including to the numerous variants and subvariants, and to the variety of available vaccines are unique.
Two years into the global COVID-19 pandemic, the role of serology testing to evaluate immune responses has not yet been defined. This webinar will explore the role of serology testing to assess immune status.
Bio-Rad SARS-CoV-2 products provide you and your laboratory with efficient new ways to quantitatively characterize immune responses.
LabRoots on Social:
SnapChat: labroots_inc
Two Years Into the Covid Pandemic, How Close Are We to Normal?
What comes next in COVID-19 fight two years into pandemic?
Two years into the COVID-19 pandemic
Two years into the COVID-19 Pandemic: Is the end in sight? Experts answer.
Two years into the pandemic 'COVID is not done with us'
Two Years into the COVID 19 Pandemic What are the Experiences and Learning from LMICs for future
Nearly two years into pandemic, health experts say catching COVID is inevitable | KVUE
Two years into the COVID-19 pandemic... What can serology testing tell us about immune status?
Two years into the pandemic: two COVID-19 treatments are FDA approved
Patients grapple with post-COVID-19 symptoms two years into the pandemic
Two Years In: Where are we, and What's Next in the COVID-19 Crisis, Briefing with Jonathan Gers...
Two years of COVID-19 pandemic
Why Is Covid Testing Still Difficult Two Years Into the Pandemic?
Looking back two years during the COVID-19 Pandemic
Covid-19 Pandemic Likely to Last Two Years, Report Says
Two years into the pandemic: two COVID-19 treatments are FDA approved
COVID-19 in India Two Years Later
Bruce Mellado shares insights two years into the COVID-19 pandemic
COVID-19 in SA | Two years since first hard lockdown
Marking two years since the COVID-19 pandemic started
Helani Galpaya shares insights two years into the COVID-19 pandemic
In-Depth: Covid-19's impact on Wisconsin veterans two years into the pandemic
COVID-19 Timeline: A look back at the past two years in Hawaii
Joseph Upile Matola shares insights two years into the COVID-19 pandemic
Комментарии